Skip to main content
. 2016 Jul 8;7(31):50535–50547. doi: 10.18632/oncotarget.10495

Figure 1. Peptide-binding affinity and selection of peptide candidates.

Figure 1

a. ERBB2 peptides, b. BIRC5 peptides, c. CD99 peptides. ERBB2369 (KIFGSLAFL), BIRC596methionine (LMLGEFLKL) and CD999 (LLLFGLLGV) were selected as HLA-A*0201-specific peptides with high scores in the peptide-T2 binding assay. The concentration of each peptide was 20 μg/mL. The values represent the mean MFI ± SE of three separate experiments.